Summary
John G. Webb, M.D., FRCPC is a Canadian interventional cardiologist and the McLeod Professor of Heart Valve Intervention at the University of British Columbia. He is most well known for performing the first transfemoral and the first transapical transcatheter aortic valve implantation in the world both in 2005.[1][2] He completed the first ever transcatheter mitral valve-in-valve replacement in 2009 and the first in-human TMVR (transcatheter mitral valve replacement) to be completed with the Neovasc Tiara device in 2014.[3] In addition, he was an investigator in the PARTNER trial, a randomized clinical trial demonstrating the efficacy of TAVI compared to aortic valve replacement and medical intervention.
Education edit
John G. Webb completed his undergraduate education at Simon Fraser University and graduated with his BSc (Hons) in Biology in 1978.[4] He completed medical school at the University of British Columbia in 1982.[5] He completed his internship at the University of Toronto Faculty of Medicine and completed his internal medicine residency back at the University of British Columbia in 1985. He completed a two-year fellowship in cardiology at the University of Toronto Faculty of Medicine and went to the University of California San Francisco for a two-year interventional cardiology fellowship as a Canadian Heart Foundation fellow.[6]
Career edit
He returned to UBC to work as an interventional cardiologist at St. Paul's Hospital in 1990.[7] After the world's first transcatheter aortic valve implantation was performed using an antegrade transseptal approach by Prof. Alain Cribier in 2002 at the University of Rouen, Webb developed the transapical and retrograde transfemoral transcatheter aortic valve implantation in 2006 at St. Paul's Hospital in Vancouver.[8][9] The transfemoral and transapical approach are now the two most common access routes used in TAVI today. He was appointed the McLeod Professor of Heart Valve Intervention in 2008.[10]
See also edit
- Alain Cribier - performed the first transcatheter aortic valve implantation in 2002
- TMVR Transcatheter Mitral Valve Replacement Systems
References edit
- ^ Webb, John G.; Chandavimol, Mann; Thompson, Christopher (2006). "Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery". Circulation. 113 (6): 842–850. doi:10.1161/CIRCULATIONAHA.105.582882. PMID 16461813. Retrieved 15 April 2015.
- ^ Ye, Jian; Cheung, Anson; Lichtenstein, Samuel (4 May 2006). "Transapical aortic valve implantation in humans". The Journal of Thoracic and Cardiovascular Surgery. 131 (5): 1194–1196. doi:10.1016/j.jtcvs.2006.01.026. PMID 16678621.
- ^ "First-in-human Tiara transcatheter mitral valve implantation successful". Healio. Retrieved 26 July 2017.
- ^ "SFU" (PDF). SFU. Retrieved 15 April 2015.
- ^ "John Webb, MD'82". UBC. Retrieved 15 April 2015.
- ^ "John Webb, MD'82". UBC. Retrieved 15 April 2015.
- ^ "Dr. John G. Webb M.D., FRCPC". Transcatheter Valve Interventions Inc. Archived from the original on 26 April 2015. Retrieved 15 April 2015.
- ^ Webb, John G.; Chandavimol, Mann; Thompson, Christopher (2006). "Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery". Circulation. 113 (6): 842–850. doi:10.1161/CIRCULATIONAHA.105.582882. PMID 16461813. Retrieved 15 April 2015.
- ^ Ye, Jian; Cheung, Anson; Lichtenstein, Samuel (4 May 2006). "Transapical aortic valve implantation in humans". The Journal of Thoracic and Cardiovascular Surgery. 131 (5): 1194–1196. doi:10.1016/j.jtcvs.2006.01.026. PMID 16678621.
- ^ "Dr. John G. Webb M.D., FRCPC". Transcatheter Valve Interventions Inc. Archived from the original on 26 April 2015. Retrieved 15 April 2015.